| DC Field | Value | Language |
|---|
| dc.contributor.author | Bibik, E. Yu. | - |
| dc.contributor.author | Nekrasa, I. A. | - |
| dc.contributor.author | Bibik, V. V. | - |
| dc.contributor.author | Frolov, K. A. | - |
| dc.contributor.author | Krivokolysko, S. G. | - |
| dc.date.accessioned | 2026-03-18T11:44:46Z | - |
| dc.date.available | 2026-03-18T11:44:46Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Assessment of possible biomarkers of individual representatives of 1,4-dihydropyridines by methods of molecular docking and predictor analysis / E.Yu. Bibik, I.A. Nekrasa, V.V. Bibik [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №4.-P. 246-257. - Doi: 10.18413/rrpharmacology.11.571. - Refer.: p. 256-257. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/66336 | - |
| dc.description.abstract | According to the results of predictor analysis and the results of molecular docking, among the 6 compounds of 1,4-dihydropyridines selected for analysis, the compound with lab codes SD1-874 is considered the most promising for further study due to the presence of oral bioactivity | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | preclinical studies | ru |
| dc.subject | in silico analysis | ru |
| dc.subject | 1,4-dihydropyridines | ru |
| dc.subject | biomarkers | ru |
| dc.subject | molecular docking | ru |
| dc.subject | predictor analysis | ru |
| dc.title | Assessment of possible biomarkers of individual representatives of 1,4-dihydropyridines by methods of molecular docking and predictor analysis | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 4
|
